Sign In

Greg Verdine

Scientist, Entrepreneur, Educator, Investor, Biotech Founder-Builder, Radical innovator

Greg Verdine is a distinguished scientist, entrepreneur, and venture capitalist who recently joined Andreessen Horowitz (a16z) as a Venture Partner on their Bio + Health team.12 His career spans academia, biotechnology, and entrepreneurship, making him a valuable addition to the a16z team.

Academic Background

Verdine served as the Erving Professor of Chemistry at Harvard University and Harvard Medical School for over three decades, where he is now Emeritus faculty.2 During his time in academia, he made significant contributions to the understanding of epigenetic DNA modification and DNA damage repair mechanisms.2

Entrepreneurial Achievements

Greg Verdine is a serial entrepreneur who has founded or co-founded numerous biotech companies, including:

  • Enanta Pharmaceuticals (ENTA)
  • Gloucester Pharmaceuticals (acquired by Celgene)
  • Wave Life Sciences (WVE)
  • FogPharma
  • Lifemine Therapeutics (current co-founder/CEO)2

His companies have achieved notable success, with three FDA-approved drugs on the market and more than 10 drugs across multiple modalities currently in development.2

Expertise in Drug Discovery

Verdine is renowned for his work in "drugging the undruggable," focusing on developing new drug modalities to target previously inaccessible disease-causing proteins.1 He co-founded the field of chemical biology and has been instrumental in inventing new drug modalities, such as stapled peptides.2

Role at Andreessen Horowitz

As a Venture Partner at a16z Bio + Health, Verdine brings his extensive experience in navigating the discovery and development of novel therapeutics.2 He spends a couple of days a month at Andreessen Horowitz, contributing to building the firm's life sciences portfolio.3

Greg Verdine's unique combination of scientific expertise, entrepreneurial success, and visionary approach to drug discovery makes him an invaluable asset to the a16z team and the broader biotech ecosystem.

Highlights

May 1 · linkedin

What a special experience to have attended and spoken at the Stanford Drug Discovery Symposium, #SDDS2024. This meeting is just simply outstanding, one-of-a-kind. Shown here with the incomparable Robert Plenge, who with his usual clarity and aplomb discussed his systematic approach toward target selection and prosecution, dialing in the right targets, the right modality, the right patients and the right execution. Kudos and thanks to the organizers Joseph C. Wu, Sanjay Malhotra, Kuldev Singh, Mark Mercola, Amanda Chase and Francesca Mae G. Tongco.

Mar 14 · linkedin

It's always a source of intense pride to see a company that you created and built from zero-to-one featured among such a stellar cohort of innovation-forward companies. I strongly believe the recognition of Wave Life Sciences is deserved, and that this is a breakout year for the company. Congratulations Paul Bolno and team! Thanks to all our investors and to our current partners Tony Wood and GSK and Andy Plump and Takeda for believing in the company, its people, its mission and its unique ability to positively impact human life, health and welfare.

Related Questions

What are some of the most significant achievements of Greg Verdine in the biotech industry?
How did Greg Verdine's work at Harvard influence his career in biotech?
What is the concept of "drugging the undruggable" and how did Greg Verdine contribute to it?
Can you provide examples of the biotech companies founded by Greg Verdine?
What role does Greg Verdine play at Andreessen Horowitz?
Greg Verdine
Greg Verdine, photo 1
Greg Verdine, photo 2
Add to my network

Location

Boston, Massachusetts, United States